Flexion Therapeutics, Inc. Gross Profit
Flexion Therapeutics, Inc. reported Gross Profit of $19.95 million for the 3-month period ending 2020-12-31, per its 10-K filed 2021-03-10.
Discontinued › Income Statement
us-gaap:GrossProfit · last filed 2021-03-10
- Flexion Therapeutics, Inc. gross profit for the quarter ending 2020-12-31 was $19.95M, a 1.13% increase year-over-year.
- Flexion Therapeutics, Inc. gross profit for the quarter ending 2020-09-30 was $18.53M, a 2.01% decline year-over-year.
- Flexion Therapeutics, Inc. gross profit for the quarter ending 2020-06-30 was $9.97M, a 35.90% decline year-over-year.
- Flexion Therapeutics, Inc. gross profit for the quarter ending 2020-03-31 was $17.85M, a 102.81% increase year-over-year.
| Period end | Gross Profit 3 month | Gross Profit 6 month | Gross Profit 9 month | Gross Profit 12 month |
|---|---|---|---|---|
| 2020-12-31 | $19.95M 10-K · filed 2021-03-10 | $38.48M derived: sum of 2 quarters · filed 2021-03-10 | $48.45M derived: sum of 3 quarters · filed 2021-03-10 | $66.30M derived: sum of 4 quarters · filed 2021-03-10 |
| 2020-09-30 | $18.53M 10-K · filed 2021-03-10 | $28.50M derived: sum of 2 quarters · filed 2021-03-10 | $46.35M derived: sum of 3 quarters · filed 2021-03-10 | $66.08M derived: sum of 4 quarters · filed 2021-03-10 |
| 2020-06-30 | $9.97M 10-K · filed 2021-03-10 | $27.82M derived: sum of 2 quarters · filed 2021-03-10 | $47.55M derived: sum of 3 quarters · filed 2021-03-10 | $66.46M derived: sum of 4 quarters · filed 2021-03-10 |
| 2020-03-31 | $17.85M 10-K · filed 2021-03-10 | $37.58M derived: sum of 2 quarters · filed 2021-03-10 | $56.49M derived: sum of 3 quarters · filed 2021-03-10 | $72.05M derived: sum of 4 quarters · filed 2021-03-10 |
| 2019-12-31 | $19.73M 10-K · filed 2021-03-10 | $38.64M derived: sum of 2 quarters · filed 2021-03-10 | $54.19M derived: sum of 3 quarters · filed 2021-03-10 | $63.00M derived: sum of 4 quarters · filed 2021-03-10 |
| 2019-09-30 | $18.91M 10-K · filed 2021-03-10 | $34.47M derived: sum of 2 quarters · filed 2021-03-10 | $43.27M derived: sum of 3 quarters · filed 2021-03-10 | $50.74M derived: sum of 4 quarters · filed 2021-03-10 |
| 2019-06-30 | $15.55M 10-K · filed 2021-03-10 | $24.36M derived: sum of 2 quarters · filed 2021-03-10 | $31.83M derived: sum of 3 quarters · filed 2021-03-10 | $37.20M derived: sum of 4 quarters · filed 2021-03-10 |
| 2019-03-31 | $8.80M 10-K · filed 2021-03-10 | $16.27M derived: sum of 2 quarters · filed 2021-03-10 | $21.64M derived: sum of 3 quarters · filed 2021-03-10 | $24.49M derived: sum of 4 quarters · filed 2021-03-10 |
| 2018-12-31 | $7.47M 8-K · filed 2020-05-20 | $12.84M derived: sum of 2 quarters · filed 2020-05-20 | $15.69M derived: sum of 3 quarters · filed 2020-05-20 | $15.19M derived: sum of 4 quarters · filed 2020-05-20 |
| 2018-09-30 | $5.37M 8-K · filed 2020-05-20 | $8.22M derived: sum of 2 quarters · filed 2020-05-20 | $7.72M derived: sum of 3 quarters · filed 2020-05-20 | $8.07M derived: sum of 4 quarters · filed 2020-05-20 |
| 2018-06-30 | $2.85M 8-K · filed 2020-05-20 | $2.35M derived: sum of 2 quarters · filed 2020-05-20 | $2.70M derived: sum of 3 quarters · filed 2020-05-20 | $2.70M derived: sum of 4 quarters · filed 2020-05-20 |
| 2018-03-31 | -$504.00K 8-K · filed 2020-05-20 | -$153.00K derived: sum of 2 quarters · filed 2020-05-20 | -$153.00K derived: sum of 3 quarters · filed 2020-05-20 | -$153.00K derived: sum of 4 quarters · filed 2020-05-20 |
| 2017-12-31 | $351.00K 10-K · filed 2019-02-28 | $351.00K derived: sum of 2 quarters · filed 2019-02-28 | $351.00K derived: sum of 3 quarters · filed 2019-02-28 | $351.00K derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-09-30 | $0.00 10-K · filed 2019-02-28 | $0.00 derived: sum of 2 quarters · filed 2019-02-28 | $0.00 derived: sum of 3 quarters · filed 2019-02-28 | |
| 2017-06-30 | $0.00 10-K · filed 2019-02-28 | $0.00 derived: sum of 2 quarters · filed 2019-02-28 | ||
| 2017-03-31 | $0.00 10-K · filed 2019-02-28 |